Estrogen, Diet, Genetics and Endometrial Cancer
NCT00587886 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1315
Last updated 2026-03-27
Summary
The purpose of this study is to see how people's diets, other aspects of their lifestyles, and their individual genetic makeup affect their chances of getting endometrial cancer (cancer of the uterus).
This survey will enroll several hundred women who have or have had endometrial cancer and several hundred who do not. We will compare these two groups of women to see what factors may lead to endometrial cancer.
Conditions
- Cancer
- Endometrial Cancer
- Ovarian Cancer
- Corpus Uteri
- Endometrium
Interventions
- BEHAVIORAL
-
Questionnaire
The main questionnaire will cover established risk and protective factors for endometrial and ovarian cancer, as well as other possible risk factors. This includes: menstrual history; pregnancy history; use of hormones for menopausal symptoms or other reasons; smoking history; height and weight; use of oral contraceptives and other methods of birth control; family history of cancer; medical history; demographic characteristics. We will also collect dietary data using the Gladys Block questionnaire, to which we have added a supplement to measure consumption of phytoestrogens. We will also obtain a buccal sample from each respondent as the source of DNA for genetic analysis.
- BEHAVIORAL
-
Questionnaire
The main questionnaire will cover established risk and protective factors for endometrial and ovarian cancer, as well as other possible risk factors. This includes: menstrual history; pregnancy history; use of hormones for menopausal symptoms or other reasons; smoking history; height and weight; use of oral contraceptives and other methods of birth control; family history of cancer; medical history; demographic characteristics. We will also collect dietary data using the Gladys Block questionnaire, to which we have added a supplement to measure consumption of phytoestrogens. We will also obtain a buccal sample from each respondent as the source of DNA for genetic analysis. We will conduct interviews mainly by telephone but also in person (at home or another convenient place)if the participant prefers.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Rutgers Cancer Institute of New Jersey
collaborator OTHER -
Municipal Institute of Medical Research
collaborator UNKNOWN -
Department of Health and Human Services
collaborator FED -
Penn State University
collaborator OTHER -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Mengmeng Du, ScD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 21 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-09-25
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Molecular Markers in Treatment in Endometrial Cancer
NCT00598845 ·Status: UNKNOWN
-
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
NCT04257045 ·Status: COMPLETED
-
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
NCT00899548 ·Status: COMPLETED
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Targeting Inflammation for Endometrial Cancer Prevention
NCT05407025 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Senescence in the Development of Endometrial Cancer
NCT03338985 ·Status: UNKNOWN ·Phase: NA
-
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT06893861 ·Status: RECRUITING
-
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
NCT04604613 ·Status: ACTIVE_NOT_RECRUITING
-
Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer
NCT05877404 ·Status: TERMINATED
-
Racial Disparity in Endometrial Cancer
NCT00375804 ·Status: TERMINATED
-
A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
NCT00858078 ·Status: COMPLETED
-
Biomarkers in Samples From Patients With Endometrial Cancer
NCT01199250 ·Status: WITHDRAWN
-
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
NCT00579163 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Gut Microbiome in Cancer Therapy
NCT05112614 ·Status: RECRUITING
-
Multimedia Aid for Genetic Testing in Gynecologic Oncology
NCT07084168 ·Status: RECRUITING ·Phase: NA
-
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer
NCT02560818 ·Status: COMPLETED ·Phase: NA
-
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
NCT06689956 ·Status: RECRUITING
-
Endometrial Cancer and Array CGH
NCT02833896 ·Status: COMPLETED
-
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
NCT00900289 ·Status: UNKNOWN
-
Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer
NCT02724501 ·Status: COMPLETED
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
NCT02226302 ·Status: COMPLETED
-
Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
NCT00897845 ·Status: COMPLETED
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING
-
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00757614 ·Status: UNKNOWN